Winway Health Desk
Liquid biopsy developer OncoCell MDx raises $22.2M in Series B round
An entrant into the liquid biopsy space has closed a venture capital raise of more than $20 million that it will use for its...
FDA Approves Nucala (mepolizumab) for Six to 11-Year-Old Children with Severe...
London UK - 12 September 2019 -- GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for use in...
Investors’ deep-pocket push to defend surprise medical bills
As proposals to ban surprise medical bills move through Congress and state legislatures with rare bipartisan support, physician groups have emerged as the loudest...
FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome...
FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ -- Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50...
Reports: Purdue has reached partial settlement in opioid lawsuit
Purdue Pharma has reached a tentative settlement in a lawsuit filed by thousands of governments across the country regarding the opioid epidemic, according to...
HIV-focused Gilead launches fund, pledges $2M to help transgender people
Studies show that transgender people in the U.S. are much more likely to be diagnosed with HIV than others. But with its latest funding...
Modern-Sundt Joint Venture Begins Work In Oroville
Sundt Construction, Inc. and its joint-venture partner Modern Building, Inc. recently started work on Orohealth’s new hospital in Oroville, Calif. The project will add...
Vertex strikes deal for Orkambi and Symkevi in Scotland, ramping up...
Vertex Pharmaceuticals and English health officials have for years been unable to strike a deal for cystic fibrosis drug access, but Vertex's new deal...
HGA Taps Shary Adams As Healthcare Principal in Washington, D.C.
HGA has hired Shary Adams, AIA, ACHA, EDAC, LEED AP BD+C, as its associate vice president and principal in Washington D.C. Adams will lead...
Ipca Labs plant blasted by FDA for a ‘cascade of failure’
An Ipca Laboratories plant savaged in an FDA warning letter three years ago continues to fail manufacturing standards that would assure its drugs are...
